Copperwynd Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-21,935
| Closed | -$670K | – | 151 |
|
2024
Q2 | $670K | Buy |
21,935
+2,724
| +14% | +$83.2K | 0.22% | 94 |
|
2024
Q1 | $533K | Buy |
19,211
+5,153
| +37% | +$143K | 0.19% | 99 |
|
2023
Q4 | $405K | Sell |
14,058
-305
| -2% | -$8.78K | 0.16% | 104 |
|
2023
Q3 | $476K | Sell |
14,363
-883
| -6% | -$29.3K | 0.22% | 91 |
|
2023
Q2 | $559K | Buy |
15,246
+967
| +7% | +$35.5K | 0.26% | 93 |
|
2023
Q1 | $583K | Buy |
14,279
+204
| +1% | +$8.32K | 0.3% | 77 |
|
2022
Q4 | $721K | Sell |
14,075
-229
| -2% | -$11.7K | 0.41% | 57 |
|
2022
Q3 | $626K | Sell |
14,304
-1,188
| -8% | -$52K | 0.36% | 55 |
|
2022
Q2 | $812K | Sell |
15,492
-44,002
| -74% | -$2.31M | 0.48% | 44 |
|
2022
Q1 | $3.08M | Sell |
59,494
-63,275
| -52% | -$3.28M | 1.28% | 17 |
|
2021
Q4 | $7.25M | Buy |
122,769
+109,434
| +821% | +$6.46M | 2.75% | 8 |
|
2021
Q3 | $574K | Buy |
13,335
+628
| +5% | +$27K | 0.24% | 85 |
|
2021
Q2 | $498K | Sell |
12,707
-849
| -6% | -$33.3K | 0.21% | 98 |
|
2021
Q1 | $491K | Buy |
13,556
+84
| +0.6% | +$3.04K | 0.22% | 88 |
|
2020
Q4 | $496K | Sell |
13,472
-32
| -0.2% | -$1.18K | 0.24% | 74 |
|
2020
Q3 | $470K | Sell |
13,504
-275
| -2% | -$9.57K | 0.25% | 64 |
|
2020
Q2 | $427K | Sell |
13,779
-947
| -6% | -$29.3K | 0.24% | 68 |
|
2020
Q1 | $456K | Buy |
14,726
+2,236
| +18% | +$69.2K | 0.22% | 41 |
|
2019
Q4 | $464K | Sell |
12,490
-1,616
| -11% | -$60K | 0.25% | 87 |
|
2019
Q3 | $494K | Buy |
14,106
+2,354
| +20% | +$82.4K | 0.28% | 80 |
|
2019
Q2 | $483K | Sell |
11,752
-38
| -0.3% | -$1.56K | 0.28% | 59 |
|
2019
Q1 | $475K | Sell |
11,790
-989
| -8% | -$39.8K | 0.28% | 55 |
|
2018
Q4 | $529K | Sell |
12,779
-2,250
| -15% | -$93.1K | 0.33% | 29 |
|
2018
Q3 | $628K | Buy |
+15,029
| New | +$628K | 0.38% | 36 |
|